Almanack Investment Partners’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-884	Closed	-$32K	–	716
2022 Q3	$32K	Buy	+884	New	+$32K	0.01%	319